Although there are no approved medications to treat levodopa-induced dyskinesias, several strategies are commonly used. Reducing the interval and amount of each dose of levodopa, maximizing the dose
of dopamine agonists, and even liquefying the daily levodopa and giving it in small hourly increments are useful in selected patients. The present study evaluates clozapine in a double-blind, placebo-controlled trial as a treatment for levodopa-induced dyskinesias.
The NIH has halted the estrogen-alone wing of the Womens Health Initiative a year before its scheduled end.
Cholesterol and Coronary Heart Disease. Altern Med Alert 2004;7(4):S1-S2.
Greenfield RH. Safety of niacin. Altern Med Alert 2004;7(4):48.
Greenfield RH. Antibacterial soaps and infectious disease. Altern Med Alert 2004;7(4):47-48.
Sasser H, Barringer T. Policosanol: A natural alternative for lipid management? Altern Med Alert 2004;7(4):37-41.
Migraine and Subclinical Brain Lesions; Memantine Treatment in Alzheimer Disease; PPG in Type 2 DM
